Jones Day has announced that Yang Xu has joined the firm’s office in Shanghai as of counsel, in its intellectual property practice. Xu arrives from Simcere Pharmaceutical Group, where he was chief patent counsel.
“Yang’s patent experience in the pharmaceutical industry will be of immense value to our clients with opportunities in these areas,” says Peter Wang, partner-in-charge of the office. Xu’s practice focuses on patent litigation and prosecution, R&D collaboration and licensing, and IP counseling. He has more than a decade of diverse IP experience in patent procurement, patent litigation, patent strategy, IP licensing, IP due diligence, and trade secret protection. As chief patent counsel for Simcere Pharmaceutical Group, he built and led its IP department and played a key role in IP protection and R&D collaborations with international and domestic pharmaceutical companies in the fields of small molecule drugs and biologics.